Open Access Journals Promotions

Submit Manuscript Other Thematic Issue Proposal Browse Thematic Issue Become a Reviewer
Share this:

Visibility on Science Direct (Elsevier) also if published as Open Access.

Member Institutions enjoy complementary or discounted APCs.

Quick and simple submission process.

TREATMENT OF CARDIOVASCULAR DISEASE IN CHRONIC AND END STAGE KIDNEY DISEASE

Journal: Current Vascular Pharmacology
Guest Editor(s): Dr. Stefanos Roumeliotis
Co-Guest Editor(s): Vassilios Liakopoulos
Submission closes on: 31st December, 2025

Submit Manuscript
Impact Factor Current: 2.8
5 - Year: 3.5
View Impact Factor Journals
Scopus CiteScore9.2 View Details

Introduction

Cardiovascular disease still remains the leading cause of death in Chronic and End Stage Kidney Disease, accounting for more than half of all deaths in dialysis patients. During the past decade, research has been focused on novel therapeutic agents that might delay or even reverse cardiovascular disease and vascular calcification, In this Thematic Issue, the novel proposed therapeutic options for the management of Cardiovascular disease in both CKD and ESKD are presented.

Keywords

Cardiovascular disease, Chronic Kidney Diseas?, End Stage Kidney Disease, Hemodialysis, Peritoneal Dialysis, Vascular Calcification

© 2025 Bentham Science Publishers | Privacy Policy